Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
All content for Oncology Unscripted is the property of Katie Coleman, Julie Johnson, Matt Spraker and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
Send us a text Welcome to Oncology Unscripted! In this new podcast, patient advocates Julie Johnson and Katie Coleman team up with radiation oncologist Dr. Matt Spraker to "meet in the middle" for a candid podcast about cancer for patients and doctors. In the premier episode, Julie and Katie share their diagnosis stories to kick off a conversation about their initial experiences. We cover a wide range of topics: getting diagnosed in a breast center versus the emergency room, types of scans ...
Oncology Unscripted
Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
